Pentoxifylline treatment for microangiopathic hemolytic anemia caused by mechanical heart valves.
The use of pentoxifylline increased the hematocrit and eliminated the transfusion requirement for a patient who had microangiopathic hemolytic anemia due to three prosthetic heart valves.
Geller
S
S
Howard County General Hospital, MD, USA.
Gelber
R
R
D000368:Aged; D000743:Anemia, Hemolytic / Q000188:drug therapy* / Q000209:etiology; D001021:Aortic Valve; D001705:Bioprosthesis / Q000009:adverse effects*; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006400:Hematocrit; D006401:Hematologic Agents / Q000627:therapeutic use*; D006801:Humans; D008943:Mitral Valve; D010431:Pentoxifylline / Q000627:therapeutic use*; D014261:Tricuspid Valve
D006401:Hematologic Agents; D010431:Pentoxifylline